siRNA molecules targeting STAT3 have demonstrated promising effects, such as reduced expression levels of STAT3-regulated proteins, reduced proliferation, and increased apoptosis in various types of cancer, including ovarian carcinoma (Sun et al., 2015; Han et al., 2013). This evidence concerns the gene STAT3 and ovarian carcinoma.